Article
BioMed Intelligence, Inc (BMI) unveiled RxVector, BMI's new pharmacy management system specifically designed to address the unique challenges encountered by specialty pharmacies.
BioMed Intelligence, Inc (BMI) unveiled RxVector, BMI’s new pharmacy management system specifically designed to address the unique challenges encountered by specialty pharmacies. BMI’s RxVector offers a full service, fully integrated and completely customizable solution for specialty pharmacies including configurable work queue and order processing automation, fully customizable clinical tools organized by therapy, medication and disease state and full integration with pharmacy services business partners. RxVector is available as a standalone product or as a seamless member of BMI’s Innovative Reporting Suite, which includes the BMI’s Interactive Web Portal & Dashboard, BMI’s RxCube, and BMI’s Query Engine (BQE), thereby providing specialty pharmacies with a single platform to meet their operational as well as internal and external reporting needs.
RxVector supports a streamlined and efficient specialty pharmacy operation resulting in reduced operating expenses and increased patient satisfaction. RxVector’s key features include:
According to Jim Maguire, BMI’s chief executive officer, “We are excited to introduce RxVector, the industry’s only fully integrated and customizable platform that empowers specialty pharmacies to improve patient care, realize cost reductions and increase profitability. By supporting the critical functions of pharmacy management, patient care management, and robust reporting on a single fully integrated platform, BMI’s RxVector solution is a truly unique and much needed solution for the specialty pharmacy industry.”
About BioMed Intelligence, Inc
BioMed Intelligence, Inc. (BMI) specializes in providing technology products and services for the healthcare community. BMI's robust suite of products supports critical operational and business intelligence needs of the pharmacy services industry. Utilizing leading edge technologies and industry experts, BMI delivers value to our clients through the implementation of streamlined processes, reduced costs and improved efficiencies.
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa